Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Sep;39(3):183-93.
doi: 10.1007/s13318-013-0158-5. Epub 2013 Nov 7.

Preparation and in vitro/in vivo evaluation of felodipine nanosuspension

Affiliations

Preparation and in vitro/in vivo evaluation of felodipine nanosuspension

Bhanu P Sahu et al. Eur J Drug Metab Pharmacokinet. 2014 Sep.

Abstract

The purpose of this study was to develop a nanosuspension of a poorly soluble drug felodipine by nanoprecipitation to achieve superior in vitro dissolution and high oral absorption in vivo in rats. Felodipine nanosuspensions were prepared by precipitation with ultrasonication method using polyvinyl alcohol (PVA) and hydroxy propyl methyl cellulose (HPMC) as stabilizers. The particle size of nanosuspension with PVA was 60-200 nm, while with HPMC is 300-410 nm. The in vitro dissolution and pharmacokinetics of optimized nanosuspensions were studied after oral administration in male wistar rats. The results showed significant improvement during in vitro dissolution and in vivo plasma level. Dissolution studies of lyophillised nanoparticles showed that up to 93.0 % dissolved in 2 h. In the in vivo evaluation, nanosuspension exhibited significant increase in AUC0-24, C max and decrease in t max. The findings revealed that particle size reduction can influence felodipine absorption in gastrointestinal tract and nanosuspension can enhance oral bioavailability of felodipine in rats.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Int J Pharm. 2005 Sep 14;301(1-2):199-208 - PubMed
    1. Int J Pharm. 2006 Aug 31;320(1-2):23-9 - PubMed
    1. J Pharm Pharmacol. 2004 Jul;56(7):827-40 - PubMed
    1. Int J Pharm. 2008 Feb 28;350(1-2):338-43 - PubMed
    1. J Microencapsul. 2005 Mar;22(2):193-203 - PubMed

MeSH terms

LinkOut - more resources